BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20815042)

  • 1. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
    Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
    Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.
    Serafino A; Moroni N; Zonfrillo M; Andreola F; Mercuri L; Nicotera G; Nunziata J; Ricci R; Antinori A; Rasi G; Pierimarchi P
    Oncotarget; 2014 Feb; 5(4):978-92. PubMed ID: 24657851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.
    Khare V; Dammann K; Asboth M; Krnjic A; Jambrich M; Gasche C
    Inflamm Bowel Dis; 2015 Feb; 21(2):287-96. PubMed ID: 25569743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4, IgA and EpCAM Expression in Colorectal Cancer and Their Possible Association with Microbiota as a Pathogenic Factor; An Immunohistochemical and Genetic Study.
    Hafez FS; Shakweer MM; Sabry D; Tawfik AM; El-Beah SM; Elsheshtawy NM; Shash LS; Salama DEA; Gaballah A
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):627-636. PubMed ID: 38415550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis.
    Walsh S; Murphy M; Silverman M; Odze R; Antonioli D; Goldman H; Loda M
    Am J Pathol; 1999 Nov; 155(5):1511-8. PubMed ID: 10550307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.
    Kłos P; Dabravolski SA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors.
    Nagayama S; Yamada E; Kohno Y; Aoyama T; Fukukawa C; Kubo H; Watanabe G; Katagiri T; Nakamura Y; Sakai Y; Toguchida J
    Cancer Sci; 2009 Mar; 100(3):405-12. PubMed ID: 19134005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of single-cell transcriptome reveals heterogeneity and commonality in the immune microenvironment of colorectal cancer and inflammatory bowel disease.
    Lv H; Mu Y; Zhang C; Zhao M; Jiang P; Xiao S; Sun H; Wu N; Sun D; Jin Y
    Front Immunol; 2024; 15():1356075. PubMed ID: 38529274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent nuclear β-catenin expression in pulmonary enteric-type adenocarcinoma according to the current World Health Organization criteria.
    Kishikawa S; Hayashi T; Takamochi K; Ura A; Sasahara N; Saito T; Suzuki K; Yao T;
    Virchows Arch; 2023 Nov; 483(5):699-703. PubMed ID: 37740071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding.
    Lewis A; Freeman-Mills L; de la Calle-Mustienes E; Giráldez-Pérez RM; Davis H; Jaeger E; Becker M; Hubner NC; Nguyen LN; Zeron-Medina J; Bond G; Stunnenberg HG; Carvajal JJ; Gomez-Skarmeta JL; Leedham S; Tomlinson I
    Cell Rep; 2014 Aug; 8(4):983-90. PubMed ID: 25131200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms.
    Frigerio S; Lartey DA; D'Haens GR; Grootjans J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice.
    Badia-Ramentol J; Gimeno-Valiente F; Duréndez E; Martínez-Ciarpaglini C; Linares J; Iglesias M; Cervantes A; Calon A; Tarazona N
    Cancer Treat Rev; 2023 Dec; 121():102643. PubMed ID: 37871463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-fat diet plus HNF1A variant promotes polyps by activating β-catenin in early-onset colorectal cancer.
    Song H; Sontz RA; Vance MJ; Morris JM; Sheriff S; Zhu S; Duan S; Zeng J; Koeppe E; Pandey R; Thorne CA; Stoffel EM; Merchant JL
    JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37219942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease.
    Chen T; Shi N; Afzali A
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31163684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive Oxygen Species and Ferroptosis at the Nexus of Inflammation and Colon Cancer.
    Huang W; Aabed N; Shah YM
    Antioxid Redox Signal; 2023 Sep; 39(7-9):551-568. PubMed ID: 36792928
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer.
    Xia Y; Zhang L; Ocansey DKW; Tu Q; Mao F; Sheng X
    Front Endocrinol (Lausanne); 2023; 14():1242991. PubMed ID: 37881499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links.
    Jurjus A; Eid A; Al Kattar S; Zeenny MN; Gerges-Geagea A; Haydar H; Hilal A; Oueidat D; Matar M; Tawilah J; Hussein IH; Schembri-Wismayer P; Cappello F; Tomasello G; Leone A; Jurjus RA
    BBA Clin; 2016 Jun; 5():16-24. PubMed ID: 27051585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a novel cell line and xenotransplant mouse model derived from feline colorectal adenocarcinoma.
    Uneyama M; Chambers JK; Fujii T; Nakashima K; Uchida K
    Vet Pathol; 2024 Mar; 61(2):190-200. PubMed ID: 37515543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulators of G-Protein Signaling (RGS) in Sporadic and Colitis-Associated Colorectal Cancer.
    Swierczynski M; Kasprzak Z; Makaro A; Salaga M
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Immunohistochemical Scoring System of CDX2 Expression as a Prognostic Biomarker in Colon Cancer.
    Ilie-Petrov AC; Cristian DA; Grama FA; Chitul A; Blajin A; Popa A; Mandi DM; Welt L; Bara MA; Vrîncianu R; Ardeleanu CM
    Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.